Literature DB >> 31620234

Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State.

Rui Liu1, Viktor Krchnak1,2, Seth N Brown1, Marvin J Miller1.   

Abstract

Substituted nitrobenzothiazinones (BTZs) are potent antituberculosis prodrugs that are reductively activated to produce nitroso moieties that form covalent adducts with a cysteine residue of decaprenylphosphoryl-β-d-ribose-2'-oxidase (DprE1) of Mycobacterium tuberculosis (Mtb). The resulting cell wall synthesis inhibition is lethal to Mtb, leading to consideration of development of BTZs for clinical use. The hydride-induced reduction of the nitroaromatic proceeds by reversible formation of the corresponding Meisenheimer complex. Herein we demonstrate that chemical reduction of BTZ043 with NaBD4 followed by reoxidation incorporates deuterium into the core nitro aromatic warhead. Subsequent reduction of the deuterated species is not affected, but, as expected, reoxidation is slowed by the deuterium isotope effect, thus prolonging the lifetime of the active nitroso oxidation state.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31620234      PMCID: PMC6792150          DOI: 10.1021/acsmedchemlett.9b00308

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  14 in total

1.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

2.  DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.

Authors:  Miroslav Brecik; Ivana Centárová; Raju Mukherjee; Gaëlle S Kolly; Stanislav Huszár; Adela Bobovská; Emöke Kilacsková; Veronika Mokošová; Zuzana Svetlíková; Michal Šarkan; João Neres; Jana Korduláková; Stewart T Cole; Katarína Mikušová
Journal:  ACS Chem Biol       Date:  2015-04-29       Impact factor: 5.100

3.  Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.

Authors:  Jennifer Furin; Andreas H Diacon; Koen Andries
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

4.  In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation.

Authors:  Florian Kloss; Viktor Krchnak; Anna Krchnakova; Sebastian Schieferdecker; Julia Dreisbach; Volker Krone; Ute Möllmann; Michael Hoelscher; Marvin J Miller
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-18       Impact factor: 15.336

5.  Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.

Authors:  Claudia Trefzer; Monica Rengifo-Gonzalez; Marlon J Hinner; Patricia Schneider; Vadim Makarov; Stewart T Cole; Kai Johnsson
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

6.  Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Authors:  Vadim Makarov; Giulia Manina; Katarina Mikusova; Ute Möllmann; Olga Ryabova; Brigitte Saint-Joanis; Neeraj Dhar; Maria Rosalia Pasca; Silvia Buroni; Anna Paola Lucarelli; Anna Milano; Edda De Rossi; Martina Belanova; Adela Bobovska; Petronela Dianiskova; Jana Kordulakova; Claudia Sala; Elizabeth Fullam; Patricia Schneider; John D McKinney; Priscille Brodin; Thierry Christophe; Simon Waddell; Philip Butcher; Jakob Albrethsen; Ida Rosenkrands; Roland Brosch; Vrinda Nandi; Sowmya Bharath; Sheshagiri Gaonkar; Radha K Shandil; Venkataraman Balasubramanian; Tanjore Balganesh; Sandeep Tyagi; Jacques Grosset; Giovanna Riccardi; Stewart T Cole
Journal:  Science       Date:  2009-03-19       Impact factor: 47.728

Review 7.  Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis.

Authors:  C R Horsburgh; M Haxaire-Theeuwes; C Lienhardt; C Wingfield; D McNeeley; L Pyne-Mercier; S Keshavjee; F Varaine
Journal:  Int J Tuberc Lung Dis       Date:  2012-12-04       Impact factor: 2.373

8.  Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.

Authors:  João Neres; Florence Pojer; Elisabetta Molteni; Laurent R Chiarelli; Neeraj Dhar; Stefanie Boy-Röttger; Silvia Buroni; Elizabeth Fullam; Giulia Degiacomi; Anna Paola Lucarelli; Randy J Read; Giuseppe Zanoni; Dale E Edmondson; Edda De Rossi; Maria Rosalia Pasca; John D McKinney; Paul J Dyson; Giovanna Riccardi; Andrea Mattevi; Stewart T Cole; Claudia Binda
Journal:  Sci Transl Med       Date:  2012-09-05       Impact factor: 17.956

9.  Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.

Authors:  Ana Luisa de Jesus Lopes Ribeiro; Giulia Degiacomi; Fanny Ewann; Silvia Buroni; Maria Loreto Incandela; Laurent R Chiarelli; Giorgia Mori; Jaeseung Kim; Monica Contreras-Dominguez; Young-Sam Park; Sung-Jun Han; Priscille Brodin; Giovanna Valentini; Menico Rizzi; Giovanna Riccardi; Maria Rosalia Pasca
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

10.  Towards a new combination therapy for tuberculosis with next generation benzothiazinones.

Authors:  Vadim Makarov; Benoit Lechartier; Ming Zhang; João Neres; Astrid M van der Sar; Susanne A Raadsen; Ruben C Hartkoorn; Olga B Ryabova; Anthony Vocat; Laurent A Decosterd; Nicolas Widmer; Thierry Buclin; Wilbert Bitter; Koen Andries; Florence Pojer; Paul J Dyson; Stewart T Cole
Journal:  EMBO Mol Med       Date:  2014-02-05       Impact factor: 12.137

View more
  1 in total

1.  Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds.

Authors:  Rui Liu; Lowell Markley; Patricia A Miller; Scott Franzblau; Gauri Shetye; Rui Ma; Karin Savková; Katarína Mikušová; Bei Shi Lee; Kevin Pethe; Garrett C Moraski; Marvin J Miller
Journal:  RSC Med Chem       Date:  2021-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.